Intellectual Property Issues in Life Sciences
Disputes and Controversies
-
10% KEDVEZMÉNY?
- A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
- Kiadói listaár GBP 110.00
-
55 671 Ft (53 020 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 10% (cc. 5 567 Ft off)
- Discounted price 50 104 Ft (47 718 Ft + 5% áfa)
55 671 Ft
Beszerezhetőség
Becsült beszerzési idő: A Prosperónál jelenleg nincsen raktáron, de a kiadónál igen. Beszerzés kb. 3-5 hét..
A Prosperónál jelenleg nincsen raktáron.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadás sorszáma 1
- Kiadó CRC Press
- Megjelenés dátuma 2024. november 15.
- ISBN 9781032522319
- Kötéstípus Keménykötés
- Terjedelem290 oldal
- Méret 234x156 mm
- Súly 453 g
- Nyelv angol
- Illusztrációk 9 Illustrations, black & white; 25 Illustrations, color; 1 Halftones, color; 10 Line drawings, black & white; 23 Line drawings, color; 30 Tables, black & white 772
Kategóriák
Rövid leírás:
This book presents expert opinions by frontier academicians, researchers, and attorneys on the recent challenges in the rapidly evolving life science industry.
TöbbHosszú leírás:
Intellectual Property Issues in Life Sciences: Disputes and Controversies highlights emerging legal, social, and regulatory issues pertaining to various areas of life sciences. Patents occupy a prominent position in the innovation systems in the life sciences, but to what extent they support, or hinder innovation is widely disputed. Life science is a broad subject including agriculture, ecology, microbiology, plant and animal sciences, health and diseases, biotechnology, etc. However, despite the broad applications of biotechnology and molecular biology techniques, profits on investments are surprisingly low. Thus, it is vitally important for universities, public research organizations, and private enterprises to protect their innovations. There are vast differences of opinion on patentability of living organisms, which are largely barred from patent protection. However, mind-sets are rapidly shifting and IP issues in life sciences are receiving increasing attention. To compete with progressive bio-based economies the developing countries are amending their IP laws to encourage investment.
An effort has been made to avoid considering policy in isolation, but rather to emphasize the interplay between the policy mix, the wider institutional setting, market forces, and system organization solutions. Both empirical and conceptual chapters are included to bring them together and to yield facts and interpretations for the readers.
This book presents expert opinions by frontier academicians, researchers, and attorneys on the recent challenges in the rapidly evolving life science industry. The present book offers comprehensive knowledge on the contemporary issues in life sciences to a wide range of audiences including students, scholars, researchers, legal practitioners, policymakers, and others interested in emerging intellectual property issues.
Features
- The only compilation available on the contemporary intellectual property issues in life sciences in the post-COVID era
- Focuses on the commercial, regulatory, bioethical, and socio-legal implications of patents in life sciences
- Describes an integrated approach for sustained innovations in various areas of life sciences
- Discusses the recent IP controversies in a pan-global context
- Presents viewpoints to front-line practitioners, viz attorneys, researchers, etc
Tartalomjegyzék:
The Need for Global Regulation of Gene Editing in the Wake of CRISPR?Cas9
IP Flexibilization for Accelerating the Achievement of the UN 2030 Agenda: Lessons from AIDS Programs in Brazil, India, Thailand, and Indonesia
Cancer Drugs Patent Disputes: Balancing Innovation, Access, and Ethics
Patent Disputes and Access to COVID-19 Vaccines: Structural Heterogeneity and Lessons for Disease X Preparedness
Analysis of Factors Associated With Patent Quality in Tissue Engineering
Vaccine Preparedness for Highly Pathogenic Avian Influenza: Innovation and Intellectual Property Issues
Intellectual Property Issues in Life Sciences: Contemporary Challenges and Considerations
Navigating Regulatory Challenges and Intellectual Property Rights for Gene-Edited Crops: Implications for Plant Breeders, Farmers, and Consumers in a Changing Climate
IP Rights and Food
Patents in Microbial ?-Glucans and Pigments: Potential Commercial Products
Menthol: The Story of a Plant-Derived Molecule Through the Patents
Technology Transfer in the Field of Biotechnology: Concepts, Actors, Models, and Processes
